Syros Pharmaceuticals, Inc. - SYRS Net Assets per Single Share

Graphic logo of Syros Pharmaceuticals (SYRS)

The final book value per share demonstrates capital resilience, where -0.41 shows the current value of the metric. The business dynamics of Syros Pharmaceuticals (SYRS) depend on the phases of clinical trials in oncology, remaining independent of market cycles. The humanitarian status of its developments minimizes geopolitical risks and external sanctions. High profitability is ensured by diversified bio-raw material logistics and a reliable pool of laboratory contractors.

Syros (SYRS) Equity per Share: for the period 07/04/2022 - 03/29/2025

syros.com - analytical breakdowns and key metrics (SYRS)

- price and consensus price forecast:
Price Chart Syros|SYRS - Fair Value Consensus
- market capitalization data:
Market Value Syros Pharmaceuticals, Inc.|SYRS - Company Buyout Price
- book capitalization data:
Book Value per Share Syros Pharmaceuticals|SYRS - Accounting Capitalization|Market Value to Book Value Ratio syros.com|SYRS - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Syros Pharmaceuticals|SYRS - Long-Term Debt to Capital|Short-Term Debt to Equity Syros Pharmaceuticals, Inc.|SYRS - Company Total Debt Obligations|Debt to Book Value Syros Pharmaceuticals, Inc.
Initial company analysis:Syros, SYRS
Manufactured products of Syros Pharmaceuticals, Inc.

Book value per share reflects the portion of equity attributable to a single security after deducting all liabilities, serving as an indicator of the business's intrinsic value. By analyzing the book value per share chart, an investor can see the capital management efficiency of Syros Pharmaceuticals (SYRS), which is optimized by outsourcing production and testing to third-party contractors to concentrate resources on genomic research.

Competitor analysis for Syros Pharmaceuticals

Net Assets per Single Share Tempus AI, Inc. (TEM)|QGEN: Accounting Value of a Share|Ionis Pharmaceuticals - Net Assets per Single Share|repligen.com (RGEN) - Net Assets per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|sarepta.com - Book Value per Share|Net Assets per Single Share TWST (Twist Bioscience, Inc.)|10x Genomics Inc (TXG) - Net Assets per Share|Accounting Value per Share NTLA|STOK (Stoke Corp) - Net Asset Value per Share|BLFS - Net Assets per Single Share|Accounting Value of a Share WVE|Maze Therapeutics - Net Assets per Single Share|Net Asset Value per Share SION (Sionna Therapeutics, Inc.)|Net Assets per Single Share PRME|TSHA - Net Assets per Share|Accounting Value per Share uniQure N.V. (QURE)|MGTX: Accounting Value of a Share|Net Assets per Single Share REGENXBIO (RGNX)|Solid Biosciences Inc (SLDB) - Share Book Value|OCGN - Book Value per Share|Accounting Value of a Share PacBio Corp|Book Value per Share BNTC|Book Value per Share DSGN (designtx.com)|Net Assets per Single Share Rocket Pharmaceuticals, Inc.|4DMT - Accounting Value of a Share|LXEO: Net Assets per Single Share|KRRO - Accounting Value per Share|EDIT: Book Value per Share|silence-therapeutics.com (SLN) - Book Value per Share|Book Value per Share PRQR|Accounting Value per Share Codexis Bio|Sangamo - Book Value per Share|Net Asset Value per Share nautilus.bio NAUT|Accounting Value per Share MGX (Metagenomi, Inc.)|DTIL - Book Value per Share|Accounting Value per Share Generation Bio Corp GBIO|BOLD - Book Price of a Share|exicuretx.com - Book Value per Share|Imunon (IMNN) - Net Assets per Share|Book Value per Share PHIO|Accounting Value per Share Mustang Bio Corp|Book Value per Share RNAZ|Book Value per Share BNGO (bionanogenomics.com)|Net Assets per Single Share Applied DNA APDN|bluebird bio, Inc - Net Assets per Single Share|Net Assets per Single Share IPA (ImmunoPrecise)|OMGA: Net Assets per Share|Singular Genomics - Net Assets per Single Share|Net Assets per Share Regulus Therapeutics, Inc.|Accounting Value per Share TBIO (Codex DNA)|Net Asset Value per Share TCON|Unity Biotechnology (UBX) - Net Assets per Single Share